Maquet Cardiovascular
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Maquet Cardiovascular sits in the upper quartile of US sponsors by registered trial count (#2,913 of 15,742 sponsors by registered trial count).
Maquet Cardiovascular: 4 sponsored US clinical trials, 1 recruiting.
Maquet Cardiovascular sponsors 4 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 1 completed. 0 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Off Pump Coronary Artery Bypass Surgery, with 1 trials.
Upper-quartile sponsor footprint
Maquet Cardiovascular sits in the upper quartile of the sponsor corpus (#2,913 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
4 total, page 1 of 1
Getinge's Beating Heart Product Family Post-Market Clinical Follow-up (PMCF) Study
NCT07286890
Study Comparing Synthetic Vascular Grafts in Patients With Peripheral Artery Disease (PAD) Who Require Artery Bypass.
NCT01113892
Prospective Clinical Study of the Guidant Microwave Ablation System for the Treatment of PAF in the MIS Procedure
NCT00415558
The Boston Scientific ACCESS Trial
NCT00260728
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
Therapeutic Areas
What is open in the Maquet Cardiovascular pipeline
1 recruiting of 4 indexed (25% open); 1 completed (25%).
Phase mix: 0 late (III/IV) vs 1 early (I/II) (early-phase heavy).
Top condition: Off Pump Coronary Artery Bypass Surgery (1 trial), 0 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Maquet Cardiovascular: open-pipeline peers nationwide
Peers matched on 4 registered trials and 25% open enrollment, not the therapeutic-area sidebar.
Maquet Cardiovascular sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 4 trials (± recruiting share)
- 4D pharma · 4 trials · 0% recruiting
- 60 Degrees Pharmaceuticals · 4 trials · 50% recruiting
- A2 Biotherapeutics · 4 trials · 75% recruiting
- Abdul Latif Jameel Poverty Action Lab · 4 trials · 25% recruiting
Sponsors near 25% open enrollment (± trial volume)
- AB Science · 25% recruiting · 8 trials
- Abbott Point of Care · 25% recruiting · 8 trials
- Accutar Biotechnology · 25% recruiting · 4 trials
- Adrienne G. Waks · 25% recruiting · 4 trials
Related
What to do with this Maquet Cardiovascular page
4 registered trials is a research-attention snapshot, not an endorsement of Maquet Cardiovascular or any single study.
- 1 of Maquet Cardiovascular's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Off Pump Coronary Artery Bypass Surgery is the condition Maquet Cardiovascular studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Off Pump Coronary Artery Bypass Surgery trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Maquet Cardiovascular pipeline card: 4 registered trials from official public datasets.Report a data error.